SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022

被引：3

作者：

Teran, Richard A. ^{[1
,2
,3
]}

Gagner, Alexandra ^{[2
]}

Gretsch, Stephanie ^{[2
]}

Lauritsen, Jeff ^{[2
]}

Galanto, Daniel ^{[2
]}

Walblay, Kelly ^{[2
]}

Ruestow, Peter ^{[2
]}

Korban, Colin ^{[2
]}

Pacilli, Massimo ^{[2
]}

Kern, David ^{[2
]}

Black, Stephanie R. ^{[2
]}

Tabidze, Irina ^{[2
]}

机构：

[1] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop H21-10, Atlanta, GA 30329 USA

[2] Chicago Dept Publ Hlth, Chicago, IL USA

[3] CDCP, 1600 Clifton Rd NE Mailstop H24-4, Atlanta, GA 30329 USA

来源：

EMERGING INFECTIOUS DISEASES | 2023年 / 29卷 / 11期

关键词：

CORONAVIRUS DISEASE 2019; UNITED-STATES; COVID-19; VACCINATION; INFECTION; ADULTS; HOSPITALIZATION; INDIVIDUALS; ILLNESS; RATES;

D O I：

10.3201/eid2911.230577

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection may help tailor future COVID-19 public health guidance. To determine whether HIV infection was associated with increased risk for SARS-CoV-2 reinfection, we followed adult longitudinally from their first reported infection through May 31, 2022. We matched SARS-CoV-2 laboratory data and COVID-19 vaccine administration data to Chicago's Enhanced HIV/AIDS Reporting System. Among 453,587 Chicago residents with SARS-CoV-2, a total of 5% experienced a SARS-CoV-2 reinfection, including 192/2,886 (7%) PWH and 23,642/450,701 (5%) persons without HIV. We observed higher SARS-CoV-2 reinfection incidence rates among PWH (66 [95% CI 57-77] cases/1,000 person-years) than PWOH (50 [95% CI adjusted rate of SARS-CoV-2 reinfection (1.46, 95% CI 1.27-1.68) than those without HIV. PWH should follow the recommended COVID-19 vaccine schedule, including booster doses.

引用

页码：2257 / 2265

页数：9

共 50 条

[41] Serological Markers of SARS-CoV-2 Reinfection
Siddiqui, Sameed M.
Bowman, Kathryn A.
Zhu, Alex L.
Fischinger, Stephanie
Beger, Samuel
Maron, Jenny S.
Bartsch, Yannic C.
Atyeo, Caroline
Gorman, Matthew J.
Yanis, Ahmad
Hultquist, Judd F.
Lorenzo-Redondo, Ramon
Ozer, Egon A.
Simons, Lacy M.
Talj, Rana
Rankin, Danielle A.
Chapman, Lindsay
Meade, Kyle
Steinhart, Jordan
Mullane, Sean
Siebert, Suzanne
Streeck, Hendrik
Sabeti, Pardis
Halasa, Natasha
Musk, Elon R.
Barouch, Dan H.
Menon, Anil S.
Nilles, Eric J.
Lauffenburger, Douglas A.
Alter, Galit
MBIO, 2022, 13 (01):
[42] Reinfection with SARS-CoV-2: An inconvenient truth?
Sonie, Pedro
Manuel-Silva, Jorge
Rafael, Alexandra
Amorim-Alves, Luis
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (01) : 366 - 369
[43] Epidemiological assessment of SARS-CoV-2 reinfection
Almadhi, Marwa
Alsayyad, Adel Salman
Conroy, Ronan
Atkin, Stephen
Al Awadhi, Abdulla
Al-Tawfiq, Jaffar A.
AlQahtani, Manaf
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 9 - 16
[44] Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
Kandeel, Amr
Moatasim, Yassmin
Fahim, Manal
Bahaaeldin, Hala
El-Shesheny, Rabeh
Roshdy, Wael H.
Kamel, Mina N.
Shawky, Shaymaa
Gomaa, Mokhtar
Naguib, Amel
El Guindy, Nancy
Deghedy, Ola
Kamel, Reham
Khalifa, Mohamed
Galal, Ramy
Hassany, Mohamed
Mahmoud, Galal
Kandeil, Ahmed
Afifi, Salma
Mohsen, Amira
Fattah, Mohammad Abdel
Kayali, Ghazi
Ali, Mohamed A.
Abdelghaffar, Khaled
BMC INFECTIOUS DISEASES, 2023, 23 (01)
[45] Confirmed SARS-CoV-2 infection in Scottish neonates 2020-2022: a national, population-based cohort study
Goulding, Anna
McQuaid, Fiona
Lindsay, Laura
Agrawal, Utkarsh
Auyeung, Bonnie
Calvert, Clara
Carruthers, Jade
Denny, Cheryl
Donaghy, Jack
Hillman, Sam
Hopcroft, Lisa
Hopkins, Leanne
McCowan, Colin
McLaughlin, Terry
Moore, Emily
Ritchie, Lewis
Simpson, Colin R.
Taylor, Bob
Fenton, Lynda
Pollock, Louisa
Gale, Chris
Kurinczuk, Jennifer J.
Robertson, Chris
Sheikh, Aziz
Stock, Sarah
Wood, Rachael
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2023, 108 (04): : 367 - 372
[46] Dynamics of SARS-CoV-2 Spike RBD Protein Mutation and Pathogenicity Consequences in Indonesian Circulating Variants in 2020-2022
Haykal, Nabiel Muhammad
Fadilah, Fadilah
Dewi, Beti Ernawati
Erlina, Linda
Prawiningrum, Aisyah Fitriannisa
Hegar, Badriul
GENES, 2024, 15 (11)
[47] Serological Survey of Retrovirus and Coronavirus Infections, including SARS-CoV-2, in Rural Stray Cats in The Netherlands, 2020-2022
Duijvestijn, Mirjam B. H. M.
Schuurman, Nancy N. M. P.
Vernooij, Johannes C. M.
van Leeuwen, Michelle A. J. M.
Bosch, Berend-Jan
van den Brand, Judith M. A.
Wagenaar, Jaap A. A.
van Kuppeveld, Frank J. M.
Egberink, Herman F. F.
Verhagen, Josanne H. H.
VIRUSES-BASEL, 2023, 15 (07):
[48] Spatiotemporal evolution of SARS-CoV-2 in the Bangkok metropolitan region, Thailand, 2020-2022: implications for future outbreak preparedness
Aiewsakun, Pakorn
Jamsai, Bharkbhoom
Phumiphanjarphak, Worakorn
Sawaengdee, Waritta
Palittapongarnpim, Prasit
Mahasirimongkol, Surakameth
MICROBIAL GENOMICS, 2023, 9 (12):
[49] Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate
Patel, Devanshi R.
Field, Cassandra J.
Septer, Kayla M.
Sim, Derek G.
Jones, Matthew J.
Heinly, Talia A.
Vanderford, Thomas H.
McGraw, Elizabeth A.
Sutton, Troy C.
JOURNAL OF VIROLOGY, 2021, 95 (13)
[50] Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections
Golding, Liam
Watts, Allison W.
Pitblado, Mark
Clemens, Felicity
Vineta Paramo, Marina
Shew, Jacob
Irvine, Michael A.
Abu-Raya, Bahaa
Goldfarb, David M.
Masse, Louise C.
Lavoie, Pascal M.
OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (10):

← 1 2 3 4 5 →